Surgical management of transvenous lead-induced tricuspid regurgitation in adult and pediatric patients with congenital heart disease

被引:6
作者
Huang, Ying [1 ]
Dearani, Joseph A. [1 ]
Lahr, Brian D. [2 ]
Stephens, Elizabeth H. [1 ]
Madhavan, Malini [3 ]
Cannon, Bryan C. [4 ]
Schaff, Hartzell, V [1 ]
机构
[1] Mayo Clin, Dept Cardiovasc Surg, Rochester, MN USA
[2] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA
[3] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA
[4] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN USA
关键词
tricuspid regurgitation; transvenous lead; tricuspid valve surgery; survival; reintervention; congenital heart disease; SUDDEN CARDIAC DEATH; VALVE; POPULATION; MORTALITY; SURVIVAL; DEFECTS;
D O I
10.1016/j.jtcvs.2021.10.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The objective of this study was to evaluate outcomes of surgical management of lead-induced tricuspid regurgitation (TR) in patients with congenital heart disease. Methods: We analyzed data of 54 consecutive patients who underwent tricuspid valve (TV) surgery from 1998 to 2015 for lead-induced TR. Primary end points, including mortality, TV reinterventions, and longitudinal TR measurements, were analyzed with the Kaplan-Meier method or with repeated measures proportional odds modeling. Results: The median age of patients was 48.2 years (interquartile range, 37.3-59.0 years); 31 (57.4%) were female; 2 (3.7%) were children. Thirty patients (55.6%) underwent TV repair and 24 (44.4%) had replacement, and 52 underwent concomitant cardiac procedures. Thirty-day mortality was 1.9% (repair: 3.3%, replacement: 0.0%). Five-year survival was 80.4% overall and 79.7% and 81.4% for the repair and replacement groups, respectively. In response to surgery, TR improved in both groups (each P < .001) but more with replacement than repair (P < .001); longitudinal analysis showed that TR trends observed early on favoring replacement were sustained across follow-up (P < .001). The model-estimated risk of moderate or severe TR at 5-year follow-up, conditional on having severe preoperative TR, was 74.4% for the repair and 10.7% for the replacement group. Five-year cumulative risk of TV reintervention was comparable for valve repair and replacement. Conclusions: Despite the need for concomitant cardiac procedures in most of the patients, early mortality was low after TV surgery. Survival and rate of TV reintervention were comparable for the repair and replacement groups. However, TV repair was associated with progressive TR during intermediate follow-up, especially in patients with severe preoperative TR.
引用
收藏
页码:2185 / +
页数:13
相关论文
共 22 条
[1]   Leadless cardiac pacing systems: current status and future prospects [J].
Beurskens, Niek E. G. ;
Breeman, Karel T. N. ;
Dasselaar, Kosse J. ;
Meijer, A. Chris ;
Quast, Anne-Floor B. E. ;
Tjong, Fleur V. Y. ;
Knops, Reinoud E. .
EXPERT REVIEW OF MEDICAL DEVICES, 2019, 16 (11) :923-930
[2]   Cardiac implantable device outcomes and lead survival in adult congenital heart disease [J].
Bowman, Hilary C. ;
Shannon, Kevin M. ;
Biniwale, Reshma ;
Moore, Jeremy P. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 324 :52-59
[3]   Durability of bioprostheses for the tricuspid valve in patients with congenital heart disease [J].
Burri, Melchior ;
Vogt, Manfred O. ;
Hoerer, Juergen ;
Cleuziou, Julie ;
Kasnar-Samprec, Jelena ;
Kuehn, Andreas ;
Lange, Ruediger ;
Schreiber, Christian .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2016, 50 (05) :988-993
[4]  
Cohen J., 1988, STAT POWER ANAL BEHA, P75
[5]   Tricuspid Regurgitation and Mortality in Patients With Transvenous Permanent Pacemaker Leads [J].
Delling, Francesca N. ;
Hassan, Zena K. ;
Piatkowski, Gail ;
Tsao, Connie W. ;
Rajabali, Alefiyah ;
Markson, Lawrence J. ;
Zimetbaum, Peter J. ;
Manning, Warren J. ;
Chang, James D. ;
Mukamal, Kenneth J. .
AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (06) :988-992
[6]   Congenital Heart Defects in the United States Estimating the Magnitude of the Affected Population in 2010 [J].
Gilboa, Suzanne M. ;
Devine, Owen J. ;
Kucik, James E. ;
Oster, Matthew E. ;
Riehle-Colarusso, Tiffany ;
Nembhard, Wendy N. ;
Xu, Ping ;
Correa, Adolfo ;
Jenkins, Kathy ;
Marelli, Ariane J. .
CIRCULATION, 2016, 134 (02) :101-+
[7]   PERFORATION OF TRICUSPID-VALVE BY A TRANSVENOUS PACEMAKER [J].
GOULD, L ;
REDDY, CVR ;
YACOB, U ;
TEICH, M ;
DEMARTINO, A ;
DEPALMA, D ;
GOMPRECHT, RF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 230 (01) :86-87
[8]   Effects of Tricuspid Valve Regurgitation on Outcome in Patients With Cardiac Resynchronization Therapy [J].
Grupper, Avishay ;
Killu, Ammar M. ;
Friedman, Paul A. ;
Abu Sham'a, Raed ;
Buber, Jonathan ;
Kuperstein, Rafael ;
Rozen, Guy ;
Asirvatham, Samuel J. ;
Espinosa, Raul E. ;
Luria, David ;
Webster, Tracy L. ;
Brooke, Kelly L. ;
Hodge, David O. ;
Wiste, Heather J. ;
Cha, Yong-Mei ;
Glikson, Michael .
AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (06) :783-789
[9]   The incidence of congenital heart disease [J].
Hoffman, JIE ;
Kaplan, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (12) :1890-1900
[10]   Outcomes and Echocardiographic Follow-up After Surgical Management of Tricuspid Regurgitation in Patients With Transvenous Right Ventricular Leads [J].
Huang, Ying ;
Dearani, Joseph A. ;
Saran, Nishant ;
Stulak, John M. ;
Greason, Kevin L. ;
Crestanello, Juan A. ;
Daly, Richard C. ;
Pochettino, Alberto ;
Lahr, Brian D. ;
Lin, Grace ;
Schaff, Hartzell, V .
MAYO CLINIC PROCEEDINGS, 2021, 96 (08) :2133-2144